Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

By | December 12, 2021
The emergence of COVID-19 variants such as delta and omicron have sent scientists scrambling to determine whether existing vaccinations and boosters are still effective against new strains of SARS-Cov-2.